116 results
Page 2 of 6
POS AM
l624 dzc4gs0g8dz
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
eecmw2b5ec 7wrt1zkql
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
bl41ie61ge bc98u044
11 May 22
Current report (foreign)
4:30pm
6-K
jaoi8zbki2rj9 dki
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
6-K
mepdy5jbvqndp8jdg4b
31 Mar 22
Results of General Meeting
8:41am
6-K
11ribwc1h
16 Mar 22
Current report (foreign)
8:30am
6-K
wssy cfhhtnuf9k
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
6-K
ivwdp993
28 Feb 22
Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA
12:00pm
6-K
dji7n05um3
25 Feb 22
Current report (foreign)
4:05pm
6-K
4orn89evj nlbd
31 Jan 22
Current report (foreign)
7:32am
6-K
zpp8ukpsgbinfsdzt5f
23 Nov 21
Amryt Provides Update on Regulatory Review Process for Oleogel-S1
8:04am
424B3
qzkgavva
22 Nov 21
Prospectus supplement
7:39am
424B3
gbk b6kci94
22 Nov 21
Prospectus supplement
7:38am
6-K
13l22bfu
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
6-K
EX-99.3
p6jeu15m7fhh1g z7
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
424B3
c9r6c65ddb1klglg4oj5
3 Nov 21
Prospectus supplement
7:33am
424B3
v5izbz5a
3 Nov 21
Prospectus supplement
7:32am
6-K
999ehbp
3 Nov 21
Amryt Reports Strong Q3 2021 Results
7:31am
6-K
l2gbqw
29 Oct 21
Current report (foreign)
6:05am